Antihemophilic Factor/von Willebrand Factor Complex (Human) (Wilate) and Cardiovascular complications
Result of checking the interaction of drug Antihemophilic Factor/von Willebrand Factor Complex (Human) (Wilate) and disease Cardiovascular complications for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Hemophilic patients with cardiovascular risk factors or diseases may be at the same risk to develop cardiovascular events as non-hemophilic patients when clotting has been normalized by treatment with factor VIII. Care should be exercised when using this agent in patients with cardiovascular risk factors.
Generic Name: antihemophilic factor / von willebrand factor
Brand Name: Alphanate, Humate-P, Wilate, Wilstart, Dried Factor VIII Fraction Type 8Y, Haemate P, Optivate
Synonyms: Antihemophilic and von Willebrand factor complex, Antihemophilic Factor/von Willebrand Factor Complex (Human)